BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seregni E, Ferrari L, Martinetti A, Bombardieri E. Diagnostic and prognostic tumor markers in the gastrointestinal tract. Semin Surg Oncol 2001;20:147-66. [PMID: 11398208 DOI: 10.1002/ssu.1028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Varis A, van Rees B, Weterman M, Ristimäki A, Offerhaus J, Knuutila S. DNA copy number changes in young gastric cancer patients with special reference to chromosome 19. Br J Cancer. 2003;88:1914-1919. [PMID: 12799636 DOI: 10.1038/sj.bjc.6600969] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
2 Chu LY, Peng YH, Yang T, Fang WK, Hong CQ, Huang LS, Xu LY, Li EM, Xu YW, Xie JJ. Circulating Levels of L1-cell Adhesion Molecule as a Serum Biomarker for Early Detection of Gastric Cancer and Esophagogastric Junction Adenocarcinoma. J Cancer 2020;11:5395-402. [PMID: 32742486 DOI: 10.7150/jca.41100] [Reference Citation Analysis]
3 Zhu Z, Chen Z, Chen C, Yang Z, Xuan W, Hou Y, Zuo Y, Ren S. Opposite variation tendencies of serum CA724 levels in patients with colon and rectal carcinoma. Mol Clin Oncol 2014;2:139-45. [PMID: 24649323 DOI: 10.3892/mco.2013.208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Choe WH, Lee SY, Lee JH, Shim SG, Kim YH, Rhee PL, Rhee JC, Ki CS, Kim JW, Song SY, Kim JJ. High frequency of microsatellite instability in intestinal-type gastric cancer in Korean patients. Korean J Intern Med 2005;20:116-22. [PMID: 16134765 DOI: 10.3904/kjim.2005.20.2.116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
5 Chen XZ, Zhang WK, Yang K, Wang LL, Liu J, Wang L, Hu JK, Zhang B, Chen ZX, Chen JP. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population. Mol Biol Rep. 2012;39:9031-9039. [PMID: 22752725 DOI: 10.1007/s11033-012-1774-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 5.2] [Reference Citation Analysis]
6 Debruyne PR, Waldman SA, Schulz S. Pathological staging and therapy of oesophageal and gastric cancer. Expert Opin Pharmacother 2003;4:1083-96. [PMID: 12831335 DOI: 10.1517/14656566.4.7.1083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
7 Refaely Y, Krasna MJ. Multimodality therapy for esophageal cancer. Surgical Clinics of North America 2002;82:729-46. [DOI: 10.1016/s0039-6109(02)00029-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
8 Han ES, Lee HH, Lee JS, Song KY, Park CH, Jeon HM. At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment. J Gastric Cancer 2014;14:123-8. [PMID: 25061540 DOI: 10.5230/jgc.2014.14.2.123] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]